HA
SGMT icon

HHLR Advisors’s Sagimet Biosciences SGMT Stock Holding History

HHLR Advisors’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6M Hold
724,800
– – 0.67% 18
2026
Q1 		$3.79M Hold
724,800
– – 0.23% 18
2025
Q4 		$4.29M Hold
724,800
– – 0.14% 17
2025
Q3 		$4.97M Hold
724,800
– – 0.12% 22
2025
Q2 		$5.52M Hold
724,800
– – 0.18% 23
2025
Q1 		$2.36M Hold
724,800
– – 0.07% 32
2024
Q4 		$3.26M Hold
724,800
– – 0.11% 25
2024
Q3 		$2.01M Hold
724,800
– – 0.04% 34
2024
Q2 		$2.48M Hold
724,800
– – 0.06% 51
2024
Q1 		$3.93M Sell
724,800
-724,743
-50% -$5.2M 0.09% 38
2023
Q4 		$7.86M Hold
1,449,543
– – 0.16% 31
2023
Q3 		$12.8M Buy
+1,449,543
New +$19.3M 0.28% 32

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

HHLR Advisors's SGMT Position: Q2 2026 in Review

HHLR Advisors held its Sagimet Biosciences (SGMT) position steady in Q2 2026 at 724,800 shares worth $5.6M. The position accounts for 0.67% of the portfolio, ranked #18.

HHLR Advisors first reported a position in SGMT in Q3 2023 and has held it in 12 quarters since. The position peaked at $12.8M in Q3 2023. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • HHLR Advisors held 724,800 shares of Sagimet Biosciences worth $5.6M as of Q2 2026.
  • HHLR Advisors left its Sagimet Biosciences share count unchanged in Q2 2026.
  • Sagimet Biosciences made up 0.67% of HHLR Advisors's portfolio in Q2 2026, its #18 holding.
  • HHLR Advisors first reported a position in Sagimet Biosciences in Q3 2023 and has held it in 12 quarters since.
  • HHLR Advisors's Sagimet Biosciences position peaked at $12.8M in Q3 2023.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on HHLR Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.